Boston Scientific
552 hedge funds and large institutions have $31.5B invested in Boston Scientific in 2017 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 178 increasing their positions, 227 reducing their positions, and 62 closing their positions.
145% more capital inflows, than outflows
Capital inflows: $4.29B | Capital outflows: $1.75B
22% more funds holding in top 10
Funds holding in top 10: 9 → 11 (+2)
13% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 62
0.29% more ownership
Funds ownership: 92.31% → 92.59% (+0.29%)
1% less funds holding
Funds holding: 556 → 552 (-4)
4% less call options, than puts
Call options by funds: $39.8M | Put options by funds: $41.3M
22% less repeat investments, than reductions
Existing positions increased: 178 | Existing positions reduced: 227
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.23B |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$342M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$319M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$116M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$85.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$164M |
| 2 |
Janus Henderson Investors US
Denver,
Colorado
|
-$134M |
| 3 |
Bank of New York Mellon
New York
|
-$112M |
| 4 |
State Street
Boston,
Massachusetts
|
-$94.2M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$92.6M |
BSX Hedge Fund Activity: Q1 2017 in Review
552 of the 4,035 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2017, worth a combined $31.5B — up 16% from $27.2B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new BSX positions and 62 closed out — a net gain of 8 holders — while 178 added to existing stakes and 227 trimmed.
The largest buyer was BlackRock, adding an estimated $2.23B. The largest seller was Citadel Advisors, cutting an estimated $164M.
- 552 institutional investors held Boston Scientific (BSX) as of Q1 2017, down from 556 in Q4 2016.
- Funds reported $31.5B of Boston Scientific stock for Q1 2017, up 16% quarter-over-quarter.
- 70 funds opened new Boston Scientific positions in Q1 2017 and 62 closed out, a net change of +8 holders.
- The largest Boston Scientific buyer in Q1 2017 was BlackRock, an estimated $2.23B added.
- The largest Boston Scientific seller in Q1 2017 was Citadel Advisors, an estimated $164M sold.
Based on aggregated 13F filings for Q1 2017.